HadjiminasDJ, McMastersKM, RobertsonSE, et al.Enhanced survival from cecal ligation and puncture with pentoxifylline is associated with altered neutrophil trafficking and reduced interleukin-1 beta expression but not inhibition of tumor necrosis factor synthesis. Surgery, 1994; 116:348–355.
2.
Mercer-JonesMA, ShrotriMS, HeinzelmannM, et al.Regulation of early peritoneal neutrophil migration by macrophage inflammatory protein-2 and mast cells in experimental peritonitis. J Leukoc Biol, 1999; 65:249–255.
3.
ScottMJ, HothJJ, StagnerMK, et al.CD40-CD154 interactions between macrophages and natural killer cells during sepsis are critical for macrophage activation and are not interferon gamma dependent. Clin Exp Immunol, 2004; 137:469–77.
4.
LenzAM, TurinaM, AlardP, et al.Microbial tolerance in secondary peritonitis is dose dependent. Cell Immunol, 2009; 258:98–106.
5.
KanaanZ, BarnettR, GardnerS, et al.Differential microRNA (miRNA) expression could explain microbial tolerance in a novel chronic peritonitis model. Innate Immun, 2013; 19:203–12.
6.
WickelDJ, CheadleWG, Mercer-JonesMA, GarrisonRN. Poor outcome from peritonitis is caused by disease acuity and organ failure, not recurrent peritoneal infection. Ann Surg, 1997; 225:744–753.
7.
BartlettRH, GazzanigaAB, FongSW, et al.Extracorporeal membrane oxygenator support for cardiopulmonary failure. Experience in 28 cases. J Thorac Cardiovasc Surg, 1977; 73:375–86.
8.
BartlettRH, NoyesBSJr., DrinkerPA. A simple reliable membrane oxygenator for organ perfusion. J Appl Physiol, 1970; 29:758–759.
9.
ParkPK, NapolitanoLM, BartlettRH. Extracorporeal membrane oxygenation in adult acute respiratory distress syndrome. Crit Care Clin, 2011; 27:627–646.
10.
CheadleWG, TurinaM. Infection and organ failure in the surgical patient: A tribute to seminal contributions by Hiram C. Polk, Jr, M.D. Am J Surg, 2005; 190:173–177.
11.
PolkHCJr., Lopez-MayorJF. Postoperative wound infection: A prospective study of determinant factors and prevention. Surgery, 1969; 66:97–103.
12.
CheadleWG, FranklinGA, RichardsonJD, et al.Broad-based general surgery training is a model of continued utility for the future. Ann Surg, 2004; 239:627–632.
13.
VitaleGC, CheadleWG, SadekS, et al.Computerized 24-hour ambulatory esophageal pH monitoring and esophagogastroduodenoscopy in the reflux patient. A comparative study. Ann Surg, 1984; 200:724–728.
14.
VitaleGC, CheadleWG, PatelB, et al.The effect of alcohol on nocturnal gastroesophageal reflux. JAMA, 1987; 258:2077–2079.
15.
CheadleWG, VitaleGC, MackieCR, et al.Prophylactic postoperative nasogastric decompression. A prospective study of its requirement and the influence of cimetidine in 200 patients. Ann Surg, 1985; 202:361–366.
16.
CheadleWG. The Veterans Affairs research program: Scientific and clinical excellence relevant to veterans' healthcare needs. Am J Surg, 2005; 190:655–661.
17.
AlexanderJW. Old problems, new and persistent challenges: Presidential address. Arch Surg, 1987; 122:15–20.
18.
AltemeierWA. Sepsis in surgery. Presidential address. Arch Surg, 1982; 117:107–112.
19.
BilliarTR. Making progress in an enlightened era: opportunities and obstacles. Surg Infect, 2007; 8:5–14.
20.
BlakemoreWS. Postresidency fellowships: An investment in the future. Presidential address. Arch Surg, 1988; 123:147–151.
21.
BurkeJF., AshleyA.Miles and the prevention of infection following surgery. Presidential address. Arch Surg, 1984; 119:17–19.
22.
ChaudryIH. Sepsis: Lessons learned in the last century and future directions. Arch Surg, 1999; 134:922–929.
23.
ChristouNV. Host defense mechanisms of surgical patients. Friend or foe?. Arch Surg, 1996; 131:1136–1140.
24.
CondonRE. Retrospect and prospect. Ruminations after the first decade of the Surgical Infection Society. Arch Surg, 1991; 126:19–22.
25.
DellingerEP. Surgical Infection Society—Trials and tribulations: The importance of clinical trials. Arch Surg, 1998; 133:1192–1197.
26.
DunnDL. History repeats itself. Connections and causality in the study of surgical infections. Arch Surg, 1994; 129:21–26.
27.
FischerJE. We hold these truths. Arch Surg, 1995; 130:1156–1158.
28.
FordHR. Answering the call to action: Response to the Haiti earthquake of January 12, 2010. Surg Infect, 2011; 12:89–98.
29.
FryDE. In vino veritas. Surg Infect, 2001; 2:185–191.
30.
HowardRJ. May you live in interesting times. Academic medical centers, academic societies, and the coming dominance of government and business in American medicine. Arch Surg, 1994; 129:1123–1130.
31.
LipsettPA. Passing in the night: A tipping point in surgical training. Surg Infect, 2012; 13:1–8.
32.
MarshallJC. Coming of age. Surg Infect, 2008; 9:111–120.
33.
MeakinsJL. Surgeons, surgery, and immunomodulation. Arch Surg, 1991; 126:494–498.
34.
NapolitanoLM. Perspectives in surgical infections: What does the future hold?. Surg Infect, 2010; 11:111–23.
35.
PruittBAJr.Host-opportunist interactions in surgical infection. Arch Surg, 1986; 121:13–22.
WestMA. Knowledge and truth: Answers or questions?. Surg Infect, 2003; 4:297–309.
40.
YurtRW. The making of a surgeon revisited. Arch Surg, 1992; 127:16–20.
41.
LowrySF. 2008 Surgical Infection Society presidential address: The value of connections. Surg Infect, 2009; 10:1–8.
42.
MalangoniMA. Providence: Surgical Infection Society 2000. Shock, 2000; 14:249–252.
43.
DeitchEA. Surgical Infection Society presidential address: Is the glass half full or half empty? Thoughts on the SIS and American surgery. Surg Infect, 2006; 7:5–14.
44.
BariePS. Oh Lord! I've got those clinical research blues. Surg Infect, 2004; 5:327–342.
45.
EdmistonCE, SpencerM, LewisBD, et al.Reducing the risk of surgical site infections: Did we really think SCIP was going to lead us to the promised land?. Surgical infections., 2011; 12:169–177.
46.
CipollaCM. A plague doctor. In: MiskiminHA, HerlihyD, UdovitchAL, (eds). The Medieval City. New Haven, CT: Yale University Press, 1977.
47.
BariePS. (Another) Nobel prize in physiology or medicine awarded for work in inflammation and immunity. Surg Infect, 2011; 12:337–338.
48.
WallmarkG, FinlandM. Phage types and antibiotic susceptibility of pathogenic staphylococci. Results at Boston City Hospital 1959–1960. JAMA, 1961; 175:886–897.
49.
HemminkiE, PaakkulainenA. The effect of antibiotics on mortality from infectious diseases in Sweden and Finland. Am J Publ Health, 1976; 66:1180–1184.
50.
DellingerRP, LevyMM, RhodesA, et al.Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock, 2012. Crit Care Med, 2013; 41:580–637.
51.
BurgerO, BaudischA, VaupelJW. Human mortality improvement in evolutionary context. Proc Natl Acad Sci USA, 2012; 109:18210–18214.
52.
OchmanH, MoranNA. Genes lost and genes found: evolution of bacterial pathogenesis and symbiosis. Science, 2001; 292:1096–1099.
53.
TowfighS, CheadleWG, LowrySF, et al.Significant reduction in incidence of wound contamination by skin flora through use of microbial sealant. Arch Surg, 2008; 143:885–891.
54.
FryDE. Fifty ways to cause surgical site infections. Surg Infect, 2011; 12:497–500.
55.
WalterCJ, DumvilleJC, SharpCA, et al.Systematic review and meta-analysis of wound dressings in the prevention of surgical-site infections in surgical wounds healing by primary intention. Br J Surg, 2012; 99:1185–1194.
56.
SorensenTI, NielsenGG, AndersenPK, et al.Genetic and environmental influences on premature death in adult adoptees. N Engl J Med, 1988; 318:727–732.
57.
ConsortiumEP, DunhamI, KundajeA, et al.An integrated encyclopedia of DNA elements in the human genome. Nature, 2012; 489:57–74.
58.
ShabanzadehDM, SorensenLT. Laparoscopic surgery compared with open surgery decreases surgical site infection in obese patients: a systematic review and meta-analysis. Ann Surg, 2012; 256:934–945.
59.
MbadiweT, ObiriezeAC, CornwellEE, et al.Surgical management of complicated diverticulitis: A comparison of the laparoscopic and open approaches. J Am Coll Surg, 2013; 216:782–788.
60.
IngrahamAM, CohenME, BilimoriaKY, et al.Comparison of outcomes after laparoscopic versus open appendectomy for acute appendicitis at 222 ACS NSQIP hospitals. Surgery, 2010; 148:625–635.
61.
WrayCJ, KaoLS, MillasSG, et al.Acute appendicitis: Controversies in diagnosis and management. Curr Probl Surg, 2013; 50:54–86.
62.
KhuriSF, DaleyJ, HendersonW, et al.The National Veterans Administration Surgical Risk Study: Risk adjustment for the comparative assessment of the quality of surgical care. J Am Coll Surg, 1995; 180:519–531.
63.
KhuriSF. The NSQIP: A new frontier in surgery. Surgery, 2005; 138:837–843.
64.
LawsonEH, Lee HallB, LouieR, et al.Association between occurrence of a postoperative complication and readmission: Implications for quality improvement and cost savings. Ann Surg, 2013; 258:10–18.
65.
CohenME, KoCY, BilimoriaKY, et al.Optimizing ACS NSQIP modeling for evaluation of surgical quality and eisk: Patient risk adjustment, procedure mix adjustment, procedure mix adjustment, shrinkage adjustment, and surgical focus. J Am Coll Surg, 2013; 217:336–346.e1.
66.
AHRQ_Patient_Safety_Network. Never Events. Available from: http://psnet.ahrq.gov/primer. Accessed April21, 2014.
67.
MehtsunWT, IbrahimAM, Diener-WestM, et al.Surgical never events in the United States. Surgery, 2013; 153:465–472.
68.
RosenbergerLH, PolitanoAD, SawyerRG. The surgical care improvement project and prevention of post-operative infection, including surgical site infection. Surg Infect, 2011; 12:163–168.
69.
BratzlerDW, HouckPM, RichardsC, et al.Use of antimicrobial prophylaxis for major surgery: Baseline results from the National Surgical Infection Prevention Project. Arch Surg, 2005; 140:174–182.
70.
DellingerEP, HausmannSM, BratzlerDW, et al.Hospitals collaborate to decrease surgical site infections. Am J Surg, 2005; 190:9–15.
71.
BariePS. SCIP to the Loo?. Surg Infect, 2011; 12:161–162.
72.
LeeGM, KleinmanK, SoumeraiSB, et al.Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med, 2012; 367:1428–1437.
73.
DavisJM, KuoYH, AhmedN, KuoYL. Report card on Surgical Care Improvement Project (SCIP): Nationwide inpatient sample infection data 2001–2006. Surg Infect, 2011; 12:429–434.
74.
AwadSS. Adherence to surgical care improvement project measures and post-operative surgical site infections. Surg Infect, 2012; 13:234–237.
75.
PronovostPJ, GoeschelCA, ColantuoniE, et al.Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: Observational study. BMJ, 2010; 340:c309.
76.
KazaureHS, RomanSA, SosaJA. Association of postdischarge complications with reoperation and mortality in general surgery. Arch Surg, 2012; 147:1000–1007.
77.
NeilyJ, MillsPD, Young-XuY, et al.Association between implementation of a medical team training program and surgical mortality. JAMA, 2010; 304:1693–1700.
78.
LowrySF. The evolution of an inflammatory response. Surg Infect, 2009; 10:419–425.
79.
BabrowskiT, RomanowskiK, FinkD, et al.The intestinal environment of surgical injury transforms Pseudomonas aeruginosa into a discrete hypervirulent morphotype capable of causing lethal peritonitis. Surgery, 2013; 153:36–43.
80.
WuL, EstradaO, ZaborinaO, et al.Recognition of host immune activation by Pseudomonas aeruginosa. Science, 2005; 309:774–777.
81.
FoteinouPT, CalvanoSE, LowrySF, AndroulakisIP. Translational potential of systems-based models of inflammation. Clin Translat Sci, 2009; 2:85–9.
82.
SeokJ, WarrenHS, CuencaAG, et al.Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA, 2013; 110:3507–3512.
